Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marjolijn, Leeman"'
Autor:
L Ulas Biter, Jan A Apers, Marjolijn Leeman, Jeannine Huisbrink, Julie M A Wijnand, Serge J C Verbrugge, Martin Dunkelgrun
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
IntroductionFast-track protocols often include short-term thromboprophylaxis and short length of hospital stay. These treatment strategies may negatively affect the occurrence and diagnosis of postoperative haemorrhage. Over the years, the rates of v
Externí odkaz:
https://doaj.org/article/1788208cd1ef4519a9c5c10cd0ce433d
Autor:
Ulas L Biter, Jan N. M. IJzermans, Robert C. Minnee, Loubna Outmani, Marjolijn Leeman, Hendrikus J. A. N. Kimenai, René A. Klaassen, Joke I. Roodnat
Publikováno v:
Clinical Transplantation
Clinical Transplantation, 35(3):e14208. Wiley-Blackwell Publishing Ltd
Clinical Transplantation, 35(3):e14208. Wiley-Blackwell Publishing Ltd
Patients with class II and III obesity and end-stage renal disease are often ineligible for kidney transplantation (KTx) due to increased postoperative complications and technically challenging surgery. Bariatric surgery (BS) can be an effective solu
Autor:
Marjolijn, Leeman, L Ulas, Biter, Jan A, Apers, Erwin, Birnie, Serge J C, Verbrugge, Martin, Dunkelgrun
Publikováno v:
Surgical endoscopy. 35(6)
For metabolic laparoscopic surgery, higher pressures up to 20 mmHg are often used to create a surgical field of sufficient quality. This randomized pilot study aimed to determine the feasibility, safety and tolerability of low intraabdominal pressure
Autor:
Marjolijn, Leeman, Stefanie R, van Mil, L Ulas, Biter, Jan A, Apers, Kees, Verhoef, Martin, Dunkelgrun
Publikováno v:
Surgical endoscopy. 35(2)
To optimize the postoperative phase following bariatric surgery, the enhanced recovery after bariatric surgery pathway (ERABS) has been developed. The aim of ERABS is to create a care path that is as safe, efficient and patient-friendly as possible.
Publikováno v:
Journal of Vascular Surgery. 66:1236-1238
Intravesical administration of bacille Calmette-Guérin (BCG) is considered to be the therapy of choice for treating superficial bladder carcinoma. Created from a live attenuated strain of Mycobacterium bovis, BCG is theoretically unable to cause inf